Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aiming to lower intraocular pressure, trabeculectomy remains the gold standard procedure. This report describes a novel, cost-effective modified bleb-forming filtration technique, tFlow (tube flow shunt), utilizing sterile trimmed silicone tubes from the Ahmed Glaucoma Valve (AGV), model FP7, to construct a subconjunctival filtration pathway. Here, clinical outcomes are not reported and will be evaluated in a future study. While initial findings suggest it may provide a viable alternative to other modified bleb-forming filtration techniques involving commercial devices like PreserFlo MicroShunt, EX-PRESS Glaucoma Filtration Device, and XEN Gel Stent, further investigation is necessary. Additional patient inclusion and comparative studies with different bleb-forming filtration techniques are potential areas for future research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085971PMC
http://dx.doi.org/10.7759/cureus.82399DOI Listing

Publication Analysis

Top Keywords

modified bleb-forming
12
bleb-forming filtration
12
tube flow
8
flow shunt
8
filtration techniques
8
filtration
5
shunt innovative
4
innovative cost-effective
4
cost-effective approach
4
approach modified
4

Similar Publications

Aiming to lower intraocular pressure, trabeculectomy remains the gold standard procedure. This report describes a novel, cost-effective modified bleb-forming filtration technique, tFlow (tube flow shunt), utilizing sterile trimmed silicone tubes from the Ahmed Glaucoma Valve (AGV), model FP7, to construct a subconjunctival filtration pathway. Here, clinical outcomes are not reported and will be evaluated in a future study.

View Article and Find Full Text PDF

Device-modified trabeculectomy for glaucoma.

Cochrane Database Syst Rev

March 2023

Ophthalmology & Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.

Background: Glaucoma is an optic neuropathy that leads to visual field defects and vision loss. It is the second leading cause of irreversible blindness in the world. Treatment for glaucoma aims to reduce intraocular pressure (IOP) to slow or prevent further vision loss.

View Article and Find Full Text PDF